Eli Lilly lowers insulin costs to $35.00

Drug-maker Eli Lilly said it has capped the out-of-pocket cost for insulin to $35 per month.

 In response to the financial hit many people with diabetes are taking due to the Covid 19 pandemic, Eli Lilly is lowering the cost for most of its insulin products to $35 a month  for anyone with commercial insurance or those who lack health coverage  altogether.  For more information, visit:  Eli Lilly Insulin.

Covid 19 and diabetes


There’s a lot of information out there right now about people with  diabetes being more susceptible to the coronavirus, but it’s not  entirely true. Dr. Edelman explains who is really at risk and why.

Dr. Steven Edelman is one of the nation’s top endocrinologist  (diabetes specialist). Dr. Edelman has been a type1 diabetic himself for  over 40 years.